Antimicrobial resistance not only undermines the efficacy of current treatments but also endangers the entirety of modern ...

XOMA Royalty’s acquisition of Turnstone Biologics highlights how royalty deals can revive biopharma companies and drive ...

Transmembrane proteins (TPs), also referred to as ‘integral membrane proteins’, make up between 70 % and 80 % of the total ...

The global Custom Antibody Market is valued at USD 553.05 Million in 2024 and is projected to reach a value of USD 1237.1 ...

UTIs cause burning, discomfort, and the frequent urge to urinate. If they are not treated, they can lead to more serious ...

More than a million people a year are already dying from infections caused by microbes that are resistant to treatment – it's ...

This low-tech intervention could fundamentally shift how we treat cancer patients. It’s not every day that scientists uncover ...

Unexpected immune response can limit effectiveness of phage therapy against bacterial infections by Emily Nunez, University of Maryland edited by Stephanie Baum, reviewed by Robert Egan Editors' notes ...

In the battle against aggressive breast cancer, a once-elusive target is now within reach—thanks to a breakthrough from a ...

Oak Ridge researchers are converting nuclear waste into components for targeted alpha therapy, a cancer treatment that ...

Specific way genetic material is organized in cells determines its ability to adapt to resist treatment. Scientists modulated ...